1. Introduction: The CKCS & Heart Disease
The Cavalier King Charles Spaniel (CKCS) is often described as the poster child for canine myxomatous mitral valve disease (MMVD). While MMVD is the most common acquired cardiac disease in dogs overall, no other breed demonstrates the same combination of near-universal prevalence, early onset, and predictable progression as the CKCS. For veterinarians, cardiologists, radiologists, and breeders alike, understanding how to interpret cardiac diagnostics specifically for this breed is not optional—it is essential.
According to published studies, nearly 100% of CKCS over 10 years of age will develop MMVD (Häggström et al., 1992; Parker & Kilroy-Glynn, 2012). Alarmingly, up to 50% show evidence by five years of age (Beardow & Buchanan, 1993), and soft systolic murmurs can be auscultated as early as 1–2 years in some individuals. This contrasts sharply with many other small-breed dogs, in which MMVD often presents later in life and progresses more slowly.
This extraordinary disease burden means that CKCS require earlier, more frequent, and more nuanced cardiac monitoring than the general canine population. However, traditional diagnostic thresholds—particularly radiographic measurements such as Vertebral Heart Score (VHS) and Vertebral Left Atrial Size (VLAS)—were originally derived from mixed-breed populations. Applying these generalized cutoffs to CKCS can lead to overdiagnosis, underdiagnosis, or inappropriate staging.
Breed-specific reference values are therefore critical. CKCS have unique thoracic conformation, cardiac silhouette characteristics, and disease trajectories that influence radiographic interpretation. A VHS value that might trigger concern in a Terrier or Dachshund may be entirely normal in a Cavalier. Conversely, subtle changes over time may represent meaningful progression even when absolute numbers appear only mildly elevated.
This guide provides a comprehensive, breed-specific reference for interpreting VHS and VLAS in CKCS, with practical integration into MMVD staging, screening protocols, and client communication. We will review normal values, clinical cutoffs, disease progression, monitoring strategies, and real-world case application—empowering clinicians to make more accurate, confident decisions for this uniquely vulnerable breed.
2. Breed-Specific VHS Values for CKCS
Normal VHS Values
The Vertebral Heart Score (VHS) is a standardized radiographic method for assessing overall cardiac size on lateral thoracic radiographs. In Cavalier King Charles Spaniels, multiple breed-focused studies have established the following reference values:
- Mean VHS: 10.6 ± 0.5 vertebrae (v)
- 95% reference range: 9.6–11.6 v
These values are notably higher than those of the general canine population, where the widely accepted mean VHS is 10.5 ± 0.5 v (Buchanan & Bücheler, 1995).
Comparison to General Canine Values
In practical terms, this means that a VHS of 10.5:
- Would be considered borderline to mildly enlarged in many breeds
- Is well within normal limits for a CKCS
Failure to account for this difference can result in misclassification of normal Cavaliers as having cardiomegaly, leading to unnecessary anxiety, diagnostics, or treatment.
Why CKCS Have Naturally Higher VHS
Several factors contribute to the higher baseline VHS in CKCS:
- Thoracic conformation: CKCS have relatively shorter thoraxes with rounded rib cages.
- Cardiac orientation: The heart often appears more upright and globoid.
- Body shape considerations: Compact body size with proportionally larger cardiac silhouette.
These anatomical characteristics affect how the cardiac silhouette projects onto lateral radiographs, increasing measured VHS without indicating pathology.
Clinical Implications
When evaluating a CKCS:
- A VHS up to ~11.5 v may still be normal, particularly in younger dogs.
- Breed-adjusted cutoff for suspected cardiomegaly: approximately 11.5–12.0 v
- Values above this range should prompt closer evaluation, especially if accompanied by:
- Progressive increase on serial films
- Clinical signs
- Murmur progression
When to Suspect True Cardiomegaly in CKCS
True cardiomegaly should be suspected when:
- VHS exceeds 12.0 v
- There is documented progression over time (e.g., increase ≥0.5 v)
- Enlargement is accompanied by elevated VLAS or echocardiographic changes
Importance of Serial Monitoring
Single measurements are far less informative than trends. Serial VHS assessments, ideally performed using consistent positioning and measurement tools, are invaluable in CKCS. Incremental increases often precede clinical decompensation and can guide timely intervention.
3. Breed-Specific VLAS Values for CKCS
Normal VLAS Values
The Vertebral Left Atrial Size (VLAS) specifically evaluates left atrial enlargement on lateral thoracic radiographs. For CKCS, established reference values include:
- Mean VLAS: 1.79 ± 0.3 v
- 95% reference range: 1.68–1.9 v
Interestingly, this is slightly lower than the general canine population median of approximately 1.9 v.
Interpretation in CKCS
This subtle difference highlights an important point: while CKCS may have a higher overall VHS, left atrial enlargement remains a critical marker of disease progression and should not be dismissed.
Cutoffs for Clinical Concern
In CKCS:
- VLAS >2.3 v: May indicate early left atrial enlargement
- VLAS ≥3.0 v: Strongly associated with ACVIM Stage B2 MMVD
Because left atrial dilation is a key predictor of progression to congestive heart failure (CHF), VLAS is particularly valuable in this breed.
Importance of VLAS in CKCS Monitoring
VLAS offers several advantages:
- Less affected by body conformation than VHS
- Strong correlation with echocardiographic LA:Ao ratios
- Useful when echocardiography is unavailable
For CKCS, combining VHS and VLAS provides a more complete and reliable assessment of cardiac remodeling.
4. MMVD in Cavalier King Charles Spaniels
Natural History of MMVD in CKCS
MMVD in CKCS follows a predictable yet accelerated course compared to other breeds. Degenerative changes of the mitral valve begin earlier, progress faster, and ultimately affect nearly all individuals.
Age of Onset and Progression
- Murmurs often detected by 2–3 years
- Structural valve changes present even earlier
- Progression from asymptomatic to symptomatic disease occurs more rapidly
Why CKCS Get MMVD
The breed’s susceptibility is largely genetic. Research has identified:
- Strong heritability of early-onset MMVD
- Ongoing investigation into specific genetic markers
- Polygenic inheritance patterns rather than a single mutation
Pathophysiologic Cascade
- Mitral valve prolapse and thickening
- Mitral regurgitation
- Volume overload of left atrium and ventricle
- Chamber dilation and remodeling
- Congestive heart failure
Murmur Progression
In CKCS, murmurs tend to:
- Appear early
- Increase steadily in intensity
- Correlate moderately (but not perfectly) with disease severity
A soft murmur does not exclude significant remodeling, reinforcing the value of imaging.
5. Screening & Monitoring Recommendations
Breeding Screening
Responsible breeding is essential to reducing disease burden:
- Cardiac auscultation prior to breeding
- Parents should ideally be murmur-free at breeding age
- Best practice:
- Echocardiography at 2.5 years
- Repeat at 5 years
Pet CKCS Monitoring Schedule
- Annual cardiac exam from age 1
- Echocardiography if a murmur is detected
- Thoracic radiographs with VHS and VLAS for staging
- Increased monitoring frequency as disease progresses
Home Monitoring for Owners
Owners should be educated to monitor:
- Sleeping respiratory rate
- Exercise tolerance
- Appetite and behavior changes
Early detection of subtle changes can significantly improve outcomes.
6. ACVIM Staging Considerations for CKCS
Applying ACVIM Staging
ACVIM guidelines apply to CKCS but require breed-adjusted interpretation.
Stage B2 in CKCS
Stage B2 is met when:
- Evidence of left atrial and ventricular enlargement
- Breed-adjusted VHS typically ≥11.5–12.0
- VLAS often ≥3.0
Treatment Decisions
- Pimobendan is recommended once Stage B2 criteria are met
- Early initiation in CKCS can delay onset of CHF
7. Other Cardiac Conditions in CKCS
While MMVD predominates, other conditions include:
- Mitral valve dysplasia (congenital, rare)
- Patent ductus arteriosus (uncommon)
- Combined or overlapping conditions
Differentiation relies on echocardiography and careful clinical correlation.
8. Client Communication Guide
Effective communication with CKCS owners is crucial:
- Be transparent about breed risk
- Set expectations for lifelong monitoring
- Emphasize quality of life and proactive care
- Avoid fatalism—many CKCS live long, happy lives with proper management
9. Case Example
Patient: 7-year-old CKCS
Finding: Grade III/VI left apical systolic murmur
Radiographs:
- VHS: 11.8 v
- VLAS: 2.8 v
Interpretation:
- VHS above breed-adjusted normal
- VLAS approaching Stage B2 threshold
Assessment: ACVIM Stage B2 MMVD
Plan: Initiate pimobendan, schedule echocardiography, and begin closer monitoring.
10. Key Takeaways
- Always use breed-specific reference values for CKCS
- Early and regular monitoring is essential
- VHS and VLAS allow reliable staging when echo is unavailable
- Serial measurements matter more than single values
- CTA: Use tools like RadAnalyzer for consistent, reproducible cardiac measurements
References
- Häggström J, Hansson K, Kvart C, Swenson L. Chronic valvular disease in the cavalier King Charles spaniel in Sweden. Vet Rec. 1992;131(24):549–553.
- Parker HG, Kilroy-Glynn P. Myxomatous mitral valve disease in dogs: does size matter? J Vet Cardiol. 2012;14(1):19–29.
- Beardow AW, Buchanan JW. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987–1991). J Am Vet Med Assoc. 1993;203(7):1023–1029.
- Buchanan JW, Bücheler J. Vertebral scale system to measure canine heart size in radiographs. J Am Vet Med Assoc. 1995;206(2):194–199.
Related Resources
- Breed-Specific VHS Comparison Chart - Compare VHS and VLAS values across multiple breeds
- VHS (Vertebral Heart Score) Complete Guide - Learn the fundamentals of VHS measurement
- VLAS (Vertebral Left Atrial Size) Guide - Understanding left atrial measurements
- MMVD in Dogs: Complete Guide - Understanding mitral valve disease progression and management